Surgical Science Sweden AB
The answer first
Does Surgical Science Sweden beat the market?
No, Surgical Science Sweden has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 92% of Nordic stocks
- Quality76
- Value67
- Trend79
No. 7 of 195 in healthcare
Expectations in the price
Moderate expectations
For the share to return about 9% a year from today's price, the cash Surgical Science Sweden keeps must grow about 6% a year for 10 years.
Max for seven days
Follow Surgical Science Sweden with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Surgical Science Sweden
Your first answer is free, no account needed.
Do you own Surgical Science Sweden, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Surgical Science Sweden and a few more. Free, no card.
Super Stock+46.4%In short
- Surgical Science Sweden has fallen 15.7% over the past year, including dividends.
- Overall, Surgical Science Sweden ranks better than 92% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 90.8%. The price is 81.6% below its peak now.
What do analysts think of Surgical Science Sweden?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 92% of Nordic stocks.
No. 7 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 66 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.01
- Asset turnoverSales divided by everything the company owns0.20
- Return on equityProfit divided by equity+2.3%
- Cash conversionOperating cash flow divided by profit1.83
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 24 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.6
- P/SPrice divided by sales2.9
- P/EPrice divided by earnings28.0
- P/CFPrice divided by operating cash flow15.3
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 45 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+20.7%
- 6 months+68.8%
- 9 months+81.3%
- 12 months−15.7%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Surgical Science Sweden
9 funds we follow own Surgical Science Sweden. The share is how much of the fund the stock makes up.
- Norway1
- Sweden8
- TIN Ny Teknik FSweden · TIN2.8%
- Nowo fundSweden · Nowo1.0%
- Nowo Global Fund G (SEK)Sweden · Nowo1.0%
- PLUS Hälsovård Sverige IndexSweden · PLUS0.5%
- SEB Blockchain Economy Exposure Fund A USDSweden · SEB0.3%
- Skandia Småbolag SverigeSweden · Skandia0.3%
- Augmented Reality Fund ASweden · Augmented0.1%
- Handelsbanken Nordiska Småbol (A1 NOK)Sweden · Handelsbanken0.1%
Show all 9
From the funds' latest known holdings.
About Surgical Science Sweden
Surgical Science Sweden AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 310 employees.
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexV…


See the full analysis of Surgical Science Sweden.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card